Thyroid disorder Board decisions
7,969 indexed Board decisions for Thyroid disorder.
Badges describe the whole decision, not the outcome for every condition listed. An appeal can grant one issue and deny or remand another. Check the original decision for each issue; these outcomes do not predict your claim.
- Whole decision: GrantedNovember 2023
The Veteran's thyroid cancer is found to be related to his exposure to Agent Orange during service, and service connection for this condition is granted.
- Whole decision: DeniedNovember 2023
The Board found no evidence of a relationship between the veteran's current diagnosed conditions and his military service, including exposure to contamination or toxins. Therefore, the claims for service connection were denied.
- Whole decision: GrantedNovember 2023
The Board found that discontinuance of the 100 percent rating for hypothyroidism, effective December 1, 2019, was improper and granted restoration of the 100 percent evaluation.
- Whole decision: DeniedNovember 2023
The Veteran's initial and subsequent ratings for hypothyroidism with dry skin of the lower extremities have been denied as his symptoms do not meet the criteria for a higher rating under either the old or new VA Rating Schedule.
- Whole decision: GrantedNovember 2023
The Board has granted service connection for hyperthyroidism, thyroid eye disease, dry eye syndrome, GERD, and right shoulder strain. Service connection is denied for bilateral hearing loss.
- Whole decision: Remanded (sent back)November 2023
The Board has remanded the case due to insufficient development and lack of adequate reasons or bases for its decision. The Veteran's thyroid condition is being reviewed again with additional medical opinions.
- Whole decision: Remanded (sent back)November 2023
The Board has remanded the Veteran's claims for service connection due to insufficient evidence regarding his in-service toxic exposures. The issues of type II diabetes mellitus, hypertension, prostate cancer, and thyroid disability are being remanded for further development.
- Whole decision: Remanded (sent back)November 2023
The Board has decided to remand the case due to an error in failing to provide a fully adequate VA examination, specifically addressing the ameliorative effects of the appellant's hypothyroidism medication.
- Whole decision: Remanded (sent back)November 2023
The Board has remanded the claims for service connection for prostatitis, benign prostatic hyperplasia, and hypothyroidism due to potential radiation exposure during service. The Veteran's claims will be further processed in accordance with VA procedures.
- Whole decision: GrantedNovember 2023
The Veteran's service-connected disabilities, including ischemic heart disease, diabetes mellitus type II, diabetic peripheral neuropathy of the right upper extremity, hypothyroidism, and hypertension, render him unable to secure and follow a substantially gainful occupation. As such, he is granted a total disability rating based on individual unemployability (TDIU).
- Whole decision: Remanded (sent back)November 2023
The Board has remanded the case due to insufficient evidence to adjudicate service connection for hypothyroidism, including whether it is related to herbicide exposure or secondary to diabetes.
- Whole decision: DeniedNovember 2023
The Veteran's claim for a higher rating for HTN was denied. The claim for non-compensable rating for hypothyroidism from June 9, 2022 to December 9, 2022 was granted. However, the claim for compensable rating for hypothyroidism since December 9, 2022 was denied.
- Whole decision: Remanded (sent back)November 2023
The Board has remanded the claims for service connection due to insufficient development regarding environmental exposures and a lack of adequate medical opinions.
- Whole decision: DismissedNovember 2023
The appeal concerning service connection for obstructive sleep apnea is dismissed. The Veteran's left ankle sprain, hypertension, headaches, gastritis, and thyroid condition are all granted with the appropriate ratings.
- Whole decision: GrantedNovember 2023
The Veteran's anxiety and mental disturbance attributable to hypothyroidism are rated at 30 percent, while a compensable rating for his hypothyroidism is denied.
- Whole decision: DeniedNovember 2023
The Board denied the Veteran's claim for service connection for hypothyroidism, finding that there is no evidence to support a secondary relationship between her service-connected PID with PCOS and her current condition.
- Whole decision: Remanded (sent back)PACT Act · November 2023
The Veteran's service connection claims for hypertension and hypothyroidism have been granted. The Board has also remanded the Veteran's claims for increased ratings for various peripheral neuropathy disabilities due to insufficient evidence of current disability levels.
- Whole decision: Remanded (sent back)PACT Act · November 2023
The Veteran's claims for increased ratings and service connection are being remanded due to the need for additional records and development. The Board acknowledges that some of his conditions may be related to in-service exposures, but further examination is needed.
- Whole decision: Remanded (sent back)November 2023
The Veteran's appeal for service connection of fibromyalgia, Sjogren's disease, prostate cancer, and Hashimoto's thyroid disease is remanded due to conflicting medical opinions. The Board finds a need for additional development including obtaining a medical opinion regarding the etiology of these conditions.
- Whole decision: Remanded (sent back)November 2023
The Board has remanded the case for further development due to the need for additional examinations and information about the Veteran's work history.
← Back to Thyroid disorder overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.